Artivion (AORT) | Stock Overview & Key Data
Artivion Performance Comparison
Stock Range
Today's Range
Low: $38.05
High: $40.96
on August 8, 2025
52 Week Range
Low: $21.97
High: $40.96
on April 9, 2025
on August 8, 2025
All-Time High: $44.82 on July 30, 2001
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.9B
EPS
-0.43
P/E Ratio (TTM)
N/A
Forward P/E
170.63
P/B Ratio
4.59
PEG Ratio
170.63
Div. Yield
N/A
ROE
-5.02%
Beta
1.638
Debt to Equity
62.81
Financial Highlights
Profitability
Gross Margin
64.23%
Operating Margin
11.22%
Profit Margin
-4.43%
Returns and Earnings
Return on Assets (TTM)
2.15%
Return on Equity (TTM)
-5.02%
EBITDA
$54.6M
Net Income (TTM)
$-17.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$9.66
Quarterly Revenue Growth (YoY)
15.30%
Quarterly Earnings Growth (YoY)
1.59%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Artivion AORT | 1.93B Small-cap | 32.44% | 33.91% | 43.53% | 34.17% | 45.83% | 64.79% | 80.24% | 97.83% |
| Abbott Laboratories ABT | 233.71B Mega-cap | 5.49% | 0.69% | 0.21% | 2.26% | 18.37% | 23.52% | 20.45% | 34.29% |
| Boston Scientific BSX | 152.83B Large-cap | -2.15% | 0.71% | -0.15% | -2.86% | 15.39% | 35.37% | 143.66% | 163.38% |
| Conmed CNMD | 1.69B Small-cap | 4.55% | 4.23% | -5.33% | -18.79% | -18.83% | -18.49% | -47.00% | -35.80% |
| Enovis ENOV | 1.63B Small-cap | 10.49% | -18.13% | -14.03% | -36.06% | -35.80% | -34.47% | -52.47% | -52.16% |
| QuidelOrtho QDEL | 1.62B Small-cap | 4.82% | -22.42% | -34.42% | -44.25% | -46.91% | -42.55% | -71.57% | -90.28% |
Ownership & Short Interest
Insider Ownership
4.54%
Institutional Ownership
89.36%
Shares Short
1M
Short Ratio
3.74
Short % of Shares Outstanding
3.56%
Average 10-Day Volume
497K
Average 90-Day Volume
383K
Artivion Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Artivion would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AORT's 52-week high and low?
- In the last 52 weeks, Artivion reached a high of $40.96 (on August 8, 2025) and a low of $21.97 (on April 9, 2025).
- What is the market cap and P/E ratio for AORT?
- Curious about Artivion's size and valuation? Its market capitalization stands at 1.93B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is 170.63.
- Does AORT pay dividends? If so, what's the yield?
- As for dividends, Artivion isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Artivion's main competitors or similar companies to consider before investing?
When looking at Artivion, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT233.71B Healthcare Medical Devices 23.52% 20.45% Boston Scientific
BSX152.83B Healthcare Medical Devices 35.37% 143.66% Conmed
CNMD1.69B Healthcare Medical Devices -18.49% -47.00% Enovis
ENOV1.63B Healthcare Medical Devices -34.47% -52.47% QuidelOrtho
QDEL1.62B Healthcare Medical Devices -42.55% -71.57% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Artivion Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Artivion's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -5.02%, the Debt to Equity ratio from the most recent quarter is 62.81, and its Gross Profit Margin stands at 64.23%.
- What is the recent revenue and earnings growth for AORT?
- Looking at Artivion's growth, its revenue over the trailing twelve months (TTM) was $405M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.30%, and quarterly earnings saw a YoY growth of 1.59%.
- How much of AORT stock is held by insiders and institutions?
- Wondering who owns Artivion stock? Company insiders (like executives and directors) hold about 4.54% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 89.36%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.